v3.26.1
Subsequent Events (Details 1)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Aug. 11, 2026
shares
Aug. 10, 2026
shares
$ / shares
Aug. 04, 2026
shares
$ / shares
Jul. 31, 2026
USD ($)
shares
Jul. 17, 2026
shares
Jun. 30, 2026
$ / shares
shares
Jun. 30, 2025
shares
Jun. 30, 2026
$ / shares
shares
Jun. 30, 2025
shares
Aug. 07, 2026
$ / shares
shares
Dec. 31, 2025
$ / shares
shares
Jun. 09, 2025
$ / shares
Subsequent Event [Line Items]                        
Stock options granted           0 0 0 0      
Common stock, shares issued (in shares)           2,675,412   2,675,412     2,237,912  
Common stock, par value (in dollars per share) | $ / shares           $ 0.001   $ 0.001     $ 0.001 $ 0.001
Subsequent Event                        
Subsequent Event [Line Items]                        
Description of definitive information statement On August 11, 2026, the Company filed a definitive information statement on Schedule 14C disclosing that holders representing approximately 61.3% of the Company's voting capital stock, together with the Board of Directors, approved by written consent in lieu of a meeting (i) the issuance of the Consideration Shares, which will represent more than 20% of the outstanding common stock and result in a change of control under Nasdaq Listing Rules 5635(a) and 5635(b), and (ii) the adoption of the Company’s 2026 Omnibus Incentive Plan under Nasdaq Listing Rule 5635(c). Pursuant to Rule 14c-2 under the Exchange Act, these actions may not be effected until at least 20 calendar days after the information statement is mailed to stockholders. The stockholders did not approve the Merger itself, only the share issuance and the adoption of the plan.                      
Subsequent Event | Employment Agreement | Chief Financial Officer                        
Subsequent Event [Line Items]                        
Description of Employment Agreement       On July 31, 2026, the Company entered into an employment agreement with Simon Brewer (the “Employment Agreement”), the Chief Financial Officer of the Company, whereby the Company has retained Mr. Brewer as the Chief Financial Officer of the Company to be effective upon completion of the acquisition of Cortigent for an indefinite period, provided that either party may terminate the Employment Agreement upon providing the other party with 30 days’ prior written notice. Mr. Brewer is to be paid an annual base salary of $300,000 and is eligible for an annual discretionary performance bonus. The Company has agreed to grant to Mr. Brewer stock options to purchase up to 200,000 shares of common stock at an exercise price equal to the price of the financing to be completed in connection with the acquisition of Cortigent, which options will vest as to 25% on each anniversary of the Employment Agreement. Mr. Brewer is eligible to participate in any benefit plans offered by the Company. The Company may terminate the Employment Agreement with cause at any time by paying any unpaid salary and expenses/benefits. The Company may terminate the Employment Agreement without cause, or Mr. Brewer may resign for good reason (as defined in the Employment Agreement), on 30 days prior written notice, by paying any unpaid salary and expenses/benefits plus a severance payment of six months of the annual salary and continuing any COBRA benefits for such six month period. Mr. Brewer has agreed to not solicit employees or customers for a period of 12 months following any termination of the Employment Agreement and not to disparage the Company or its past or present officers, directors, managers, employees, products, services or business.                
Annual base salary | $       $ 300,000                
Stock options vest percentage on each anniversary       25.00%                
Subsequent Event | Employment Agreement | Chief Financial Officer | Maximum [Member] | Common Stock [Member]                        
Subsequent Event [Line Items]                        
Stock options granted       200,000                
Subsequent Event | Warrant Cancellation Agreement | Warrant [Member] | First Finance | Private Placement                        
Subsequent Event [Line Items]                        
Exercise price of warrants | $ / shares     $ 5                  
Expiry term of warrants     2 years                  
Subsequent Event | Warrant Cancellation Agreement | Maximum [Member] | Common Stock [Member] | First Finance | Private Placement                        
Subsequent Event [Line Items]                        
Debt Instrument, Convertible, Number of Equity Instruments     437,500                  
Subsequent Event | Advisor Agreements | First Finance                        
Subsequent Event [Line Items]                        
Common stock, shares issued (in shares)                   25,000    
Common stock, par value (in dollars per share) | $ / shares                   $ 0.001    
Subsequent Event | Advisor Agreements | Betelgeuse Capital Advisors Inc.                        
Subsequent Event [Line Items]                        
Common stock, shares issued (in shares)                   90,000    
Subsequent Event | Advisor Agreements | Gang3 Capital Ltd.                        
Subsequent Event [Line Items]                        
Common stock, shares issued (in shares)                   140,000    
Subsequent Event | Advisor Agreements | JJK Holdings Ltd.                        
Subsequent Event [Line Items]                        
Common stock, shares issued (in shares)                   600,000    
Subsequent Event | Merger Agreement                        
Subsequent Event [Line Items]                        
Exercise price of warrants | $ / shares   $ 10                    
Expiry term of warrants   6 months                    
Subsequent Event | Merger Agreement | Maximum [Member]                        
Subsequent Event [Line Items]                        
Debt Instrument, Convertible, Number of Equity Instruments   4,285,714                    
Subsequent Event | Merger Agreement | Minimum [Member]                        
Subsequent Event [Line Items]                        
Debt Instrument, Convertible, Number of Equity Instruments   2,857,142                    
Subsequent Event | Omnibus Incentive Plan [Member]                        
Subsequent Event [Line Items]                        
Stock options granted 0       0